Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients
European Neurology · 2024
DOI: 10.1159/000538828 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Neurology, 2024. Verfasst von Edoardo Nicolò Aiello und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy, e.aiello@auxologico.it. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Feasibility Studies, Mental Status and Dementia Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Introduction
The present study aimed at testing the longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented amyotrophic lateral sclerosis (ALS) patients.
Methods
N = 39 non-demented ALS patients were followed-up at a 5-to-10-month interval (M = 6.8; SD = 1.4) with the MoCA and the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Practice effects, test-retest reliability, and predictive validity (against follow-up ECAS scores) were assessed. Reliable change indices (RCIs) were derived via a regression-based approach by accounting for retest interval and baseline confounders (i.e., demographics, disease duration, and severity and progression rate).
Results
At retest, 100% and 69.2% of patients completed the ECAS and the MoCA, respectively. Patients who could not complete the MoCA showed a slightly more severe and fast-progressing disease. The MoCA was not subject to practice effects (t[32] = −0.80; p = 0.429) and was reliable at retest (intra-class correlation = 0.82). Moreover, baseline MoCA scores predicted the ECAS at retest. RCIs were successfully derived – with baseline MoCA scores being the only significant predictor of retest performances (ps < 0.001).
Conclusions
As long as motor disabilities do not undermine its applicability, the MoCA appears to be longitudinally feasible at a 5-to-10-month interval in non-demented ALS patients. However, ALS-specific screeners – such as the ECAS – should be preferred whenever possible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy, e.aiello@auxologico.it.
- Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy.
- Neurology Residency Program, Università Degli Studi di Milano, Milano, Italy.
- Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università Degli Studi di Milano, Milano, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Zitieren
APA
Aiello, E. N., Solca, F., Torre, S., Colombo, E., Maranzano, A., De Lorenzo, A., Patisso, V., Treddenti, M., Curti, B., Morelli, C., Doretti, A., Verde, F., Ferrucci, R., Barbieri, S., Ruggiero, F., Priori, A., Silani, V., Ticozzi, N., & Poletti, B. (2024). Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients. European Neurology. https://doi.org/10.1159/000538828
Vancouver
Aiello EN, Solca F, Torre S, Colombo E, Maranzano A, De Lorenzo A, et al. Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients. European Neurology. 2024. doi:10.1159/000538828
BibTeX
@article{Aiello2024,
author = {Aiello, Edoardo Nicolò and Solca, Federica and Torre, Silvia and Colombo, Eleonora and Maranzano, Alessio and De Lorenzo, Alberto and Patisso, Valerio and Treddenti, Mauro and Curti, Beatrice and Morelli, Claudia and Doretti, Alberto and Verde, Federico and Ferrucci, Roberta and Barbieri, Sergio and Ruggiero, Fabiana and Priori, Alberto and Silani, Vincenzo and Ticozzi, Nicola and Poletti, Barbara},
title = {Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients},
journal = {European Neurology},
year = {2024},
doi = {10.1159/000538828}
}
EUVIMED